Inhibition of peptidase degrading endogenous opioids: a new trend in the management of migraine and correlated "pain diseases".
D001921:Brain / Q000201:enzymology; D002216:Captopril / Q000627:therapeutic use; D003000:Clonidine / Q000627:therapeutic use; D003027:Cluster Headache / Q000188:drug therapy; D004723:Endorphins / Q000378:metabolism*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D009619:Nociceptors / Q000187:drug effects; D010146:Pain / Q000188:drug therapy*; D011433:Propranolol / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use*
D004723:Endorphins; D011480:Protease Inhibitors; D002216:Captopril; D011433:Propranolol; D003000:Clonidine